The European Union’s medicines agency was meeting Wednesday to consider giving the green light to Moderna Inc.’s COVID-19 vaccine, a decision that would give the 27-nation bloc a
WEDNESDAY, Oct. 7, 2020 — Eli Lilly and Co. is seeking U.S. approval for emergency use of an experimental antibody therapy for COVID-19. The request to the U.S.
(HealthDay)—The first generic version of the widely used Advair Diskus inhaler for asthma and chronic obstructive pulmonary disease (COPD) has won U.S. Food and Drug Administration approval. This
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok